Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,253,000
-
Total 13F shares
-
25,035,867
-
Share change
-
-680,474
-
Total reported value
-
$335,724,442
-
Put/Call ratio
-
0%
-
Price per share
-
$13.41
-
Number of holders
-
90
-
Value change
-
-$8,276,505
-
Number of buys
-
39
-
Number of sells
-
40
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2016
As of 30 Sep 2016,
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,035,867 shares.
The largest 10 holders included
NWQ INVESTMENT MANAGEMENT COMPANY, LLC, FRANKLIN RESOURCES INC, WYNNEFIELD CAPITAL INC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, ARIEL INVESTMENTS, LLC, ROYAL BANK OF CANADA, ROYCE & ASSOCIATES LP, HEARTLAND ADVISORS INC, and THOMSON HORSTMANN & BRYANT INC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.